124I PET-based 3D-RD dosimetry for a pediatric thyroid cancer patient: Real-time treatment planning and methodologic comparison

Journal of Nuclear Medicine

Volumn 50, Issue 11, 2009, Pages 1844-1847

  Hobbs, Robert F ^a   Wahl, Richard L ^a   Lodge, Martin A ^a   Javadi, Mehrbod S ^a   Cho, Steve Y ^a   Chien, David T ^a   Ewertz, Marge E ^b   Esaias, Caroline E ^a   Ladenson, Paul W ^b   Sgouros, George ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

3D RD; Dosimetry; Oncology; PET; Radiobiology dosimetry; Radionuclide therapy; Thyroid; Treatment planning

Indexed keywords

IODINE 124; IODINE 131; DIAGNOSTIC AGENT; RADIOACTIVE IODINE;

ARTICLE; BONE MARROW TOXICITY; BRAIN METASTASIS; CALCULATION; CANCER PATIENT; CASE REPORT; CHILD; CONTROLLED STUDY; DOSIMETRY; FEMALE; GROUPS BY AGE; HUMAN; LUNG TOXICITY; OUTCOME ASSESSMENT; PAPILLARY CARCINOMA; PHYSICIAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; SCHOOL CHILD; THREE DIMENSIONAL IMAGING; THYROID CANCER; THYROIDECTOMY; TREATMENT PLANNING; TUMOR VOLUME; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; METHODOLOGY; PATHOLOGY; RADIOMETRY; SCINTISCANNING; THYROID TUMOR; TIME;

CHILD; FEMALE; HUMANS; IODINE RADIOISOTOPES; POSITRON-EMISSION TOMOGRAPHY; RADIATION DOSAGE; RADIOMETRY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; TIME FACTORS;

EID: 70350704832     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.066738     Document Type: Article

References (7)

1. Sgouros G, Frey E, Wahl R, He B, Prideaux A, Hobbs R. Three-dimensional imaging-based radiobiological dosimetry. Semin Nucl Med. 2008;38:321-334.
2. Prideaux AR, Song H, Hobbs RF, et al. Three-dimensional radiobiologic dosimetry: application of radiobiologic modeling to patient-specific 3-dimensional imaging-based internal dosimetry. J Nucl Med. 2007;48:1008-1016. (Pubitemid 46909931)
3. Press OW, Eary JF, Appelbaum FR, et al. Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. N Engl J Med. 1993;329: 1219-1224. (Pubitemid 23306322)
4. Benua R, Leeper R. A method and rationale for treating metastatic thyroid carcinoma with the largest safe dose of 131I. In: Medeiros-Neta GE, Gaitan E, eds. Frontiers in Thyroidology. New York, NY: Plenum Medical; 1986:1317-1321.
5. Freudenberg LS, Jentzen W, Muller SP, Bockisch A. Disseminated iodine-avid lung metastases in differentiated thyroid cancer: a challenge to 124I PET. Eur J Nucl Med Mol Imaging. 2008;35:502-508.
6. Steen RG, Koury BSM, Granja CI, et al. Effect of ionizing radiation on the human brain: white matter and gray matter T1 in pediatric brain tumor patients treated with conformal radiation therapy. Int J Radiat Oncol Biol Phys. 2001;49:79-91.
7. Sgouros G, Song H, Ladenson PW, Wahl RL. Lung toxicity in radioiodine therapy of thyroid carcinoma: development of a dose-rate method and dosimetric implications of the 80-mCi rule. J Nucl Med. Dec 2006;47:1977-1984. (Pubitemid 47544985)